Drug intelligence / Profile preview

ProBeptigen

Development stage
Unknown
Lead developer
Grape King Bio
Modality
Peptides
Administration
Oral
01

Overview

ProBeptigen (CMI-168) is a proprietary hydrolyzed chicken extract containing bioactive peptides derived from essence of chicken (EOC). It is developed as a cognitive enhancer and neuroprotective agent, primarily targeting age-related cognitive decline and stress-induced memory impairment. The extract functions by reducing systemic and neuroinflammation (evidenced by decreased high-sensitivity C-reactive protein levels), mitigating oxidative stress in the hippocampus, and modulating neurotransmitter levels, such as increasing dopamine. Clinical trials in healthy middle-aged adults have demonstrated that CMI-168 supplementation improves verbal memory and spatial working memory, with effects persisting even after the termination of supplementation. It has also shown potential anti-aging effects in senescence-accelerated mouse models by promoting the antioxidant defense system and protecting against mitochondrial DNA damage.

Brand names
ProBeptigen
Other names
hydrolyzed chicken extractChicken Meat Ingredient-168chicken meat hydrolysate
02

Targets

BDNF (Brain-derived neurotrophic factor)

Beyond the preview

Go deeper on ProBeptigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProBeptigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call